Stay updated with breaking news from Pocket Sky. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The research states that SSRIs, or selective serotonin reuptake inhibitors, are often prescribed drugs for the treatment of seasonal affective disorder. In the market for seasonal affective disorder treatments industry, there are numerous branded and generic drugs accessible, however Buproban and Citalopram continue...
The global Seasonal Affective Disorder (SAD) Therapeutics market demnad is poised for substantial growth, with a projected valuation close to US$ 1.1 Billion by the end of 2028. Seasonal Affective Disorder, commonly known as winter depression, is a mood disorder that affects individuals during specific seasons, typi...
The seasonal affective disorder (SAD) therapeutics market is pegged at around US$ 450 million in 2019, with a modest Y-o-Y increase of 3.9% over 2018, according to a recent intelligence report by Future Market Insights. While drugs and devices collectively contribute to the consumption volume of seasonal affective d...
Seasonal Affective Disorder Therapeutics Market: Competitive Landscape & Regional Analysis Advertisement Published 1 month ago The seasonal affective disorder (SAD) therapeutics market is pegged at around US$ 450 million in 2019, with a modest Y-o-Y increase of 3.9% over 2018, according to a recent intelligence report by Future Market Insights. While drugs and devices collectively contribute to the consumption volume of seasonal affective disorder therapeutics, the latter will remain a major shareholder in the market. Towards the end of 2019, more than 3.4 million devices are likely to be ...
Search jobs Seasonal Affective Disorder Therapeutics Market: “Bright Light Therapy” Remains First Line of Intervention The seasonal affective disorder (SAD) therapeutics market is pegged at around US$ 450 million in 2019, with a modest Y-o-Y increase of 3.9% over 2018, according to a recent intelligence report by Future Market Insights. While drugs and devices collectively contribute to the consumption volume of seasonal affective disorder therapeutics, the latter will remain a major shareholder in the market. Towards the end of 2019, more than 3.4 million devic...